J&J and Legend’s Carvykti shines at ASCO, while Junshi provides updates on anti-PD-1 antibody toripalimab. Alongside, ADCs from Biokin and BlissBio also step into the spotlight. Guest speaker Leon Tang in the US, Brian Yang in Beijing and Dexter Yan in Shanghai discuss what stood out in this special ASCO-focused episode of their latest Chinese-language podcast.
Chinese-language podcast focusing on ASCO 2023 • Source: Citeline/Shutterstock
